Risk factors for periventricular-intraventricular hemorrhage in premature infants

Periventricular-intraventricular hemorrhage (PV-IVH) is a major cause of neurological disabilities in preterm newborns. This study aimed to determine the perinatal factors associated with PV-IVH. We conducted a retrospective case-control study from preterm infants born at < or =34 weeks of gestat...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Korean medical science Vol. 25; no. 3; pp. 418 - 424
Main Authors: Lee, Ju Young, Kim, Han Suk, Jung, Euiseok, Kim, Eun Sun, Shim, Gyu Hong, Lee, Hyun Joo, Lee, Jin A, Choi, Chang Won, Kim, Ee-Kyung, Kim, Beyong Il, Choi, Jung-Hwan
Format: Journal Article
Language:English
Published: Korea (South) The Korean Academy of Medical Sciences 01-03-2010
대한의학회
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Periventricular-intraventricular hemorrhage (PV-IVH) is a major cause of neurological disabilities in preterm newborns. This study aimed to determine the perinatal factors associated with PV-IVH. We conducted a retrospective case-control study from preterm infants born at < or =34 weeks of gestation and admitted to Neonatal Intensive Care Units of Seoul National University Children's Hospital and Seoul National University Bundang Hospital between June 2003 and December 2007. Neonates with no cranial sonographic data or infants transferred from other centers after three days of age were excluded. Of 1,044 eligible subjects, 59 infants with PV-IVH grade 2, 3, and 4 were allocated to the case group. The control group consisted of 118 infants without PV-IVH who were matched for gestational age and birth weight to each case of PV-IVH. At the multivariate logistic regression model, metabolic acidosis (odds ratio [OR]: 6.94; 95% confidence interval [CI]: 1.12-43.23) and use of inotropes (OR: 3.70; 95% CI: 1.16-11.84) were associated with an increased risk of PV-IVH. Maternal use of antenatal corticosteroids decreases the risk of PV-IVH (OR: 0.36; 95% CI: 0.14-0.92).
Bibliography:G704-000345.2010.25.3.015
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0191120100250030418
ISSN:1011-8934
1598-6357
DOI:10.3346/jkms.2010.25.3.418